94 related articles for article (PubMed ID: 10028058)
21. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.
Hyun TS; Subramanian C; Cotter MA; Thomas RA; Robertson ES
J Virol; 2001 Sep; 75(18):8761-71. PubMed ID: 11507221
[TBL] [Abstract][Full Text] [Related]
22. A sensitive promoter assay based on the transcriptional activator Tat of the HIV-1 virus.
Koken SE; van Wamel J; Berkhout B
Gene; 1994 Jul; 144(2):243-7. PubMed ID: 8039709
[TBL] [Abstract][Full Text] [Related]
23. Examination of TAR-independent Trans activation by human immunodeficiency virus type 1 Tat in human glial cells.
Kim YS; Panganiban AT
J Neurosci Res; 1996 Mar; 43(6):652-66. PubMed ID: 8984195
[TBL] [Abstract][Full Text] [Related]
24. Tat transactivation of the human immunodeficiency virus type 1 promoter is influenced by basal promoter activity and the simian virus 40 origin of DNA replication.
Kessler M; Mathews MB
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10018-22. PubMed ID: 1658792
[TBL] [Abstract][Full Text] [Related]
25. Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression.
Rasty S; Thatikunta P; Gordon J; Khalili K; Amini S; Glorioso JC
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6073-8. PubMed ID: 8650221
[TBL] [Abstract][Full Text] [Related]
26. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
[TBL] [Abstract][Full Text] [Related]
27. Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein.
Chowdhury M; Taylor JP; Tada H; Rappaport J; Wong-Staal F; Amini S; Khalili K
Oncogene; 1990 Dec; 5(12):1737-42. PubMed ID: 2178236
[TBL] [Abstract][Full Text] [Related]
28. A quantitative assay for trans-activation by HIV-1 Tat, using liposome-mediated DNA uptake and a parallel ELISA system.
Watson ME; Moore M
AIDS Res Hum Retroviruses; 1993 Sep; 9(9):861-7. PubMed ID: 8257635
[TBL] [Abstract][Full Text] [Related]
29. Effect of insulin-like growth factor I on HIV type 1 long terminal repeat-driven chloramphenicol acetyltransferase expression.
Germinario RJ; Colby-Germinario SP; Acel A; Chandok R; Davison K; Mak J; Kleiman L; Faust E; Wainberg MA
AIDS Res Hum Retroviruses; 1999 Jun; 15(9):829-36. PubMed ID: 10381171
[TBL] [Abstract][Full Text] [Related]
30. Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rev proteins in transfected cells.
Harrison GS; Maxwell F; Long CJ; Rosen CA; Glode LM; Maxwell IH
Hum Gene Ther; 1991; 2(1):53-60. PubMed ID: 1863640
[TBL] [Abstract][Full Text] [Related]
31. Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin.
Verhoef K; Tijms M; Berkhout B
Nucleic Acids Res; 1997 Feb; 25(3):496-502. PubMed ID: 9016587
[TBL] [Abstract][Full Text] [Related]
32. Comparison of cis and trans tat gene expression in HIV LTR-based amplifier vectors.
Zhang T; Tsang TC; Harris DT
Biotechniques; 2002 Nov; 33(5):1146-51. PubMed ID: 12449396
[TBL] [Abstract][Full Text] [Related]
33. Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses.
Gendelman HE; Phelps W; Feigenbaum L; Ostrove JM; Adachi A; Howley PM; Khoury G; Ginsberg HS; Martin MA
Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9759-63. PubMed ID: 2432602
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of Tat-independent transcriptional processivity from the HIV-1 LTR promoter by matrix attachment regions.
Rampalli S; Kulkarni A; Kumar P; Mogare D; Galande S; Mitra D; Chattopadhyay S
Nucleic Acids Res; 2003 Jun; 31(12):3248-56. PubMed ID: 12799452
[TBL] [Abstract][Full Text] [Related]
35. Tat mediates transcriptional activation of HIV-1 gene in vitro.
West M; Hoover T; Kung H; Raziuddin
Indian J Biochem Biophys; 1995 Dec; 32(6):351-5. PubMed ID: 8714203
[TBL] [Abstract][Full Text] [Related]
36. An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity.
Zauli G; La Placa M; Vignoli M; Re MC; Gibellini D; Furlini G; Milani D; Marchisio M; Mazzoni M; Capitani S
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):306-16. PubMed ID: 7552492
[TBL] [Abstract][Full Text] [Related]
37. The Epstein-Barr virus DNA polymerase transactivates the human immunodeficiency virus type 1 5' long terminal repeat.
Lin JC
Biochem Biophys Res Commun; 1993 Aug; 195(1):242-9. PubMed ID: 8395825
[TBL] [Abstract][Full Text] [Related]
38. Human immunodeficiency virus type 1 Tat activity in human neuronal cells: uptake and trans-activation.
Kolson DL; Collman R; Hrin R; Balliet JW; Laughlin M; McGann KA; Debouck C; Gonzalez-Scarano F
J Gen Virol; 1994 Aug; 75 ( Pt 8)():1927-34. PubMed ID: 8046394
[TBL] [Abstract][Full Text] [Related]
39. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.
Roof P; Ricci M; Genin P; Montano MA; Essex M; Wainberg MA; Gatignol A; Hiscott J
Virology; 2002 Apr; 296(1):77-83. PubMed ID: 12036319
[TBL] [Abstract][Full Text] [Related]
40. Ribozyme targeting of HIV-1 LTR.
Ventura M; Wang P; Franck N; Saragosti S
Biochem Biophys Res Commun; 1994 Sep; 203(2):889-98. PubMed ID: 8093072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
